Name | MUNITSIPAL'NOE UNITARNOE PREDPRIYATIE "APTEKA N 278" |
---|
INN | 2322001556 |
---|
KPP | 232201001 |
---|
OGRN | 1032313058403 |
---|
OKPO | 1901900 |
---|
Address | 352800, Krasnodarskiy Kray, r-n Tuapsinskiy, g. Tuapse, ul. Gogolya, d. D.6 |
---|
Phone | 2-27-49 Contact details |
---|
Fax | 2-56-53 |
|
OKVED code | Type | Name of activity type |
---|
47.73 | Core activity | Retailing drugs in specialized stores (pharmacies) |
Registration date | 21.07.2003 |
---|
Registering department | Administratsiya goroda Tuapse |
---|
|
MUP "APTEKA N 278" (Krasnodar Krai; INN 2322001556) was registered on 21 Jul 2003. The company's authorized capital as of July 1, 2012 was 100000 rub. Type of ownership of MUP "APTEKA N 278" - Unitary enterprises based on the principle of economic management. Form of ownership of MUP "APTEKA N 278" - Municipal property. Principal activities of MUP "APTEKA N 278": retailing drugs in specialized stores (pharmacies) (47.73). |
Economic indicators2021
Net profit (RAS) of MUP APTEKA N 278 dropped in 2021 4.93 times to 193.00 thousand RUB from 951.00 thousand RUB over the same period in 2020, the company informed. Revenue decreased in the accounting period by 15.43% to 75.94 million RUB from 89.79 million RUB in 2020; cost of goods sold decreased by 14.20% to 54.01 million RUB from 62.94 million RUB; sales loss made up 597.00 thousand RUB compared to sales profit of 1.39 million RUB. 2020
Net profit (RAS) of MUP APTEKA N 278 grew over 2020 by 11.36% to 951.00 thousand RUB from 854.00 thousand RUB over 2019, the company informed. Revenue remained in the accounting period at the same level and made up 89.79 million RUB compared to 89.76 million RUB 89.76 million RUB; cost of goods sold decreased by 6.22% to 62.94 million RUB from 67.12 million RUB; sales profit went up by 49.68% to 1.39 million RUB from 928.00 thousand RUB. 2019
Net profit (RAS) of MUP APTEKA N 278 made up 854.00 thousand RUB over 2019 compared to net loss of 614.00 thousand RUB over 2018, the company informed. Revenue decreased in the accounting period by 3.62% to 89.76 million RUB from 93.13 million RUB in 2018; cost of goods sold decreased by 2.85% to 67.12 million RUB from 69.08 million RUB; sales profit made up 928.00 thousand RUB compared to sales loss of 274.00 thousand RUB. 2018
Net loss (RA) of MUP APTEKA N 278 made up 614.00 thousand RUB over 2018 compared to net profit of 1.20 million RUB over 2017, the company informed. Revenue increased in the accounting period by 3.22% to 93.13 million RUB from 90.22 million RUB over 2017; cost of goods sold grew by 1.43% to 69.08 million RUB from 68.11 million RUB; sales loss made up 274.00 thousand RUB compared to sales profit of 1.76 million RUB. 2017
Net profit (RAS) of MUP APTEKA N 278 dropped in 2017 by 5.58% to 1.20 million RUB from 1.27 million RUB over the same period in 2016, the company informed. Revenue decreased in the accounting period by 11.48% to 90.22 million RUB from 101.92 million RUB in 2016; cost of goods sold decreased by 11.68% to 68.11 million RUB from 77.11 million RUB; sales profit fell by 4.44% to 1.76 million RUB from 1.85 million RUB. 2016
Net profit (RAS) of MUP APTEKA N 278 dropped in 2016 by 3.71% to 1.27 million RUB from 1.32 million RUB over the same period in 2015, the company informed. Revenue decreased in the accounting period by 6.55% to 101.92 million RUB from 109.06 million RUB in 2015; cost of goods sold decreased by 7.03% to 77.11 million RUB from 82.94 million RUB; sales profit fell by 4.16% to 1.85 million RUB from 1.93 million RUB. 2014
Net profit (RAS) of MUP APTEKA N 278 grew over 2014 by 1.73% to 1.29 million RUB from 1.27 million RUB over 2013, the company informed. Revenue increased in the accounting period by 4.02% to 110.38 million RUB from 106.12 million RUB over 2013; cost of goods sold grew by 2.08% to 83.87 million RUB from 82.16 million RUB; sales profit went up by 21.93% to 2.11 million RUB from 1.73 million RUB. 2013
Net profit (RAS) of MUP APTEKA N 278 grew over 2013 by 3.34% to 1.27 million RUB from 1.23 million RUB over 2012, the company informed. Revenue increased in the accounting period by 26.74% to 106.12 million RUB from 83.73 million RUB over 2012; cost of goods sold grew by 28.88% to 82.16 million RUB from 63.75 million RUB; sales profit went up by 12.87% to 1.73 million RUB from 1.53 million RUB. 2012
Net profit (RAS) of MUP APTEKA N 278 grew over 2012 by 15.09% to 1.23 million RUB from 1.07 million RUB over 2011, the company informed. Cost of goods sold grew by 28.29% to 63.75 million RUB from 49.69 million RUB; sales profit went up by 11.35% to 1.53 million RUB from 1.38 million RUB.
unlimited access to database "Kontragent" download any information within 24 hours
Companies in the region
|